Reading this on a mobile device? Try our optimized mobile version here:

March 11, 2013
BIO has teamed up with FedEx to offer member companies discounts of up to 35% off select FedEx Express, FedEx Ground and FedEx Home Delivery services through the BIO Business Solutions cost-savings program. Learn more.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at

  Today's Top Story 
  • Takeda seeks EU approval for Crohn's and ulcerative colitis drug
    Takeda Pharmaceutical submitted an application to the European Medicines Agency for approval to sell vedolizumab, its gut-selective monoclonal antibody, as a treatment for moderately to severely active ulcerative colitis and Crohn's disease. The application was based on data from four late-stage trials involving 3,000 patients. PharmaTimes (U.K.) (3/8) LinkedInFacebookTwitterEmail this Story
  Health Care & Policy 
  • Roche's heart drug inclacumab performs well in trial
    A Phase II trial found that Roche Holding's experimental drug inclacumab significantly outperformed a placebo in reducing heart damage among heart attack patients who received angioplasty. Inclacumab significantly reduced levels of troponin I and CK-MB, molecular markers used to diagnose heart damage. Reuters (3/10) LinkedInFacebookTwitterEmail this Story
  • Toxin in bee venom kills HIV virus, researchers say
    Melittin, the toxic component of bee venom, penetrates HIV and other viruses, essentially killing the pathogens, say researchers at Washington University School of Medicine in St. Louis. They hitched melittin to nanoparticles with molecular stopgaps that prevent damage to healthy cells. Used in a vaginal gel, the toxin could prevent HIV transmission, and researchers hope the findings could be used to treat other infections. St. Louis Post-Dispatch (3/7) LinkedInFacebookTwitterEmail this Story
  Company & Financial News 
  Food & Agriculture 
  Hot Topics 

Top five news stories selected by BIO SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Industrial & Environmental 
  • Enerkem has not given up on Miss. ethanol project
    Canada-based Enerkem has not abandoned its plan to develop a waste-to-ethanol plant in Pontotoc, Miss., despite delays and setbacks to the project, including a canceled initial public offering of shares in 2012. "Enerkem is committed to realize this project and is working diligently with its local partner to complete the necessary business arrangements and move the project forward," said Annie Pare, Enerkem’s director of communications. The company has acquired land next to a landfill in Pontotoc, where construction of the facility could begin in the second half of this year, Pare said. Northeast Mississippi Daily Journal (Tupelo, Miss.) (3/10) LinkedInFacebookTwitterEmail this Story

Interested in learning more about advertising in BIO SmartBrief? Contact Meryl Harold at (202) 407-7828 or 

  News from BIO 
  • Are you taking full advantage of your membership?
    BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

The greatest way to live with honor in this world is to be what we pretend to be."
Greek philosopher

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Meryl Harold (202) 407-7828
A powerful website for SmartBrief readers including:
 Recent BIO SmartBrief Issues:   Lead Editor:  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information